Published in Biotech Business Week, December 20th, 2004
Net revenues in the quarter totaled $377.4 million compared with $322.9 million last year. Full year net revenues were $1.4 billion compared with the year ago level of $1.2 billion. In accordance with generally accepted accounting principles (GAAP), the revenue numbers exclude intersegment revenues with Genesis HealthCare Corporation (GHC) for the period prior to its spin-off on December 1, 2003.
Net revenues, as adjusted for intersegment transactions with GHC, totaled $342.2 million in the year ago quarter for a year over year...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.